• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
82,039.70 281.97
( 0.34%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.85 3.30
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

BSE Bharat 22 Index
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1016
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.59
4699447.83
EPS(TTM)
Face Value()
Div & Yield %
0
100
2.69
 

almondz global securities ltd
Shilpa Medicare gains as unit VI gets USFDA EIR with VAI classification
Jul 16,2025

The good manufacturing practice (GMP) inspection was conducted from 24 October 2024 to 30 October 2024.

This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms - oral dissolving films and transdermal systems.

The Unit is already approved by EMA, Europe; MHRA, UK; SFDA, Saudi and TGA, Australia.

This Unit is currently supplying Oral Film products to US and other markets. Transdermal products have been filed in the European market.

Shilpa Medicare is a manufacturer of API, formulation, and development services. Shilpa Medicare (SML) started its operations as an API manufacturer way back in 1987 at Raichur, Karnataka, India.

The company's consolidated net profit fell 40.77% to Rs 14.51 crore, while revenue from operations rose 13.40% to Rs 330.80 crore in Q4 FY25 over Q4 FY24.